Anwar Mahmoud Rayan
Vorstandsvorsitzender bei GeneArrest Ltd.
Profil
Anwar Mahmoud Rayan is the founder of IDD Therapeutics Ltd.
(founded in 2010) and GeneArrest Ltd.
(founded in 2009), where he holds the title of Chief Executive Officer.
Dr. Rayan's current jobs include being a Research Associate at The Hebrew University of Jerusalem and a Member-Scientific Advisory Board at Pepticom Ltd.
Dr. Rayan's education includes an undergraduate and doctorate degree from The Hebrew University of Jerusalem.
Aktive Positionen von Anwar Mahmoud Rayan
| Unternehmen | Position | Beginn |
|---|---|---|
GeneArrest Ltd.
 GeneArrest Ltd. Miscellaneous Commercial ServicesCommercial Services GeneArrest Ltd. develops drug discovery technology. Its antigene drug discovery platform is a route to capitalize on new insights in genomic information to make novel drugs. The company's technology is based on proprietary bioinformatics tools used to design selective and specific gene-silencing chemicals. GeneArrest was founded by Mizied Falah and Anwar Rayan in 2009 and is headquartered in Nazareth, Israel. | Vorstandsvorsitzender | 01.01.2009 |
| The Hebrew University of Jerusalem | Corporate Officer/Principal | - |
Pepticom Ltd.
 Pepticom Ltd. Packaged SoftwareTechnology Services Pepticom Ltd. operates as an artificial intelligence platform for peptide discovery. It offers peptide optimization, drug discovery, and small molecule discovery. The company was founded by Anwar Mahmoud Rayan, Amiram Goldblum, Immanuel Lerner and Amit Michaeli in 2011 and is headquartered in Givat-Ram, Israel. | Direktor/Vorstandsmitglied | 01.01.2011 |
Ehemalige bekannte Positionen von Anwar Mahmoud Rayan
| Unternehmen | Position | Ende |
|---|---|---|
IDD Therapeutics Ltd.
 IDD Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology IDD Therapeutics Ltd. designs, develops, and commercializes drugs for cancer therapy. The company was founded by Anwar Rayan on December 22, 2010 and is headquartered in Nazareth, Israel. | Gründer | - |
Ausbildung von Anwar Mahmoud Rayan
| The Hebrew University of Jerusalem | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
GeneArrest Ltd.
GeneArrest Ltd. Miscellaneous Commercial ServicesCommercial Services GeneArrest Ltd. develops drug discovery technology. Its antigene drug discovery platform is a route to capitalize on new insights in genomic information to make novel drugs. The company's technology is based on proprietary bioinformatics tools used to design selective and specific gene-silencing chemicals. GeneArrest was founded by Mizied Falah and Anwar Rayan in 2009 and is headquartered in Nazareth, Israel. | Commercial Services |
IDD Therapeutics Ltd.
IDD Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology IDD Therapeutics Ltd. designs, develops, and commercializes drugs for cancer therapy. The company was founded by Anwar Rayan on December 22, 2010 and is headquartered in Nazareth, Israel. | Health Technology |
Pepticom Ltd.
Pepticom Ltd. Packaged SoftwareTechnology Services Pepticom Ltd. operates as an artificial intelligence platform for peptide discovery. It offers peptide optimization, drug discovery, and small molecule discovery. The company was founded by Anwar Mahmoud Rayan, Amiram Goldblum, Immanuel Lerner and Amit Michaeli in 2011 and is headquartered in Givat-Ram, Israel. | Technology Services |
